238 related articles for article (PubMed ID: 34969660)
21. Drug Metabolism by the Host and Gut Microbiota: A Partnership or Rivalry?
Swanson HI
Drug Metab Dispos; 2015 Oct; 43(10):1499-504. PubMed ID: 26261284
[TBL] [Abstract][Full Text] [Related]
22. The gut microbiome, kidney disease, and targeted interventions.
Ramezani A; Raj DS
J Am Soc Nephrol; 2014 Apr; 25(4):657-70. PubMed ID: 24231662
[TBL] [Abstract][Full Text] [Related]
23. Gut Microbiome: The Interplay of an "Invisible Organ" with Herbal Medicine and Its Derived Compounds in Chronic Metabolic Disorders.
Lim DW; Wang JH
Int J Environ Res Public Health; 2022 Oct; 19(20):. PubMed ID: 36293657
[TBL] [Abstract][Full Text] [Related]
24. Gut microbiota modulates drug pharmacokinetics.
Zhang J; Zhang J; Wang R
Drug Metab Rev; 2018 Aug; 50(3):357-368. PubMed ID: 30227749
[TBL] [Abstract][Full Text] [Related]
25. The human gut microbiome and its dysfunctions through the meta-omics prism.
Mondot S; Lepage P
Ann N Y Acad Sci; 2016 May; 1372(1):9-19. PubMed ID: 26945826
[TBL] [Abstract][Full Text] [Related]
26. Role of the gut microbiome in cardiovascular drug response: The potential for clinical application.
Steiner HE; Gee K; Giles J; Knight H; Hurwitz BL; Karnes JH
Pharmacotherapy; 2022 Feb; 42(2):165-176. PubMed ID: 34820870
[TBL] [Abstract][Full Text] [Related]
27. Reciprocal interactions between gut microbiota and autophagy.
Lapaquette P; Bizeau JB; Acar N; Bringer MA
World J Gastroenterol; 2021 Dec; 27(48):8283-8301. PubMed ID: 35068870
[TBL] [Abstract][Full Text] [Related]
28. Integrating the gut microbiome and pharmacology.
Verdegaal AA; Goodman AL
Sci Transl Med; 2024 Jan; 16(732):eadg8357. PubMed ID: 38295186
[TBL] [Abstract][Full Text] [Related]
29. Emerging role of fecal microbiota therapy in the treatment of gastrointestinal and extra-gastrointestinal diseases.
Konturek PC; Haziri D; Brzozowski T; Hess T; Heyman S; Kwiecien S; Konturek SJ; Koziel J
J Physiol Pharmacol; 2015 Aug; 66(4):483-91. PubMed ID: 26348073
[TBL] [Abstract][Full Text] [Related]
30. A Comprehensive Review on Biotransformation, Interaction, and Health of Gut Microbiota and Bioactive Components.
Zhang L; Ma XG
Comb Chem High Throughput Screen; 2024; 27(11):1551-1565. PubMed ID: 37916626
[TBL] [Abstract][Full Text] [Related]
31. Pharmacomicrobiomics: Influence of gut microbiota on drug and xenobiotic metabolism.
Dikeocha IJ; Al-Kabsi AM; Miftahussurur M; Alshawsh MA
FASEB J; 2022 Jun; 36(6):e22350. PubMed ID: 35579628
[TBL] [Abstract][Full Text] [Related]
32. Gut Reactions: Breaking Down Xenobiotic-Microbiome Interactions.
Clarke G; Sandhu KV; Griffin BT; Dinan TG; Cryan JF; Hyland NP
Pharmacol Rev; 2019 Apr; 71(2):198-224. PubMed ID: 30890566
[TBL] [Abstract][Full Text] [Related]
33. Gut microbiomes and their metabolites shape human and animal health.
Park W
J Microbiol; 2018 Mar; 56(3):151-153. PubMed ID: 29492871
[TBL] [Abstract][Full Text] [Related]
34. Gut microbiome disruption altered the biotransformation and liver toxicity of arsenic in mice.
Chi L; Xue J; Tu P; Lai Y; Ru H; Lu K
Arch Toxicol; 2019 Jan; 93(1):25-35. PubMed ID: 30357543
[TBL] [Abstract][Full Text] [Related]
35. Human gut microbiota plays a role in the metabolism of drugs.
Jourova L; Anzenbacher P; Anzenbacherova E
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2016 Sep; 160(3):317-26. PubMed ID: 27485182
[TBL] [Abstract][Full Text] [Related]
36. Biotransformation of dietary phytoestrogens by gut microbes: A review on bidirectional interaction between phytoestrogen metabolism and gut microbiota.
Seyed Hameed AS; Rawat PS; Meng X; Liu W
Biotechnol Adv; 2020 Nov; 43():107576. PubMed ID: 32531317
[TBL] [Abstract][Full Text] [Related]
37. The metabolic effect of gut microbiota on drugs.
Xie Y; Hu F; Xiang D; Lu H; Li W; Zhao A; Huang L; Wang R
Drug Metab Rev; 2020 Feb; 52(1):139-156. PubMed ID: 32116054
[TBL] [Abstract][Full Text] [Related]
38. Insights from pharmacokinetic models of host-microbiome drug metabolism.
Zimmermann-Kogadeeva M; Zimmermann M; Goodman AL
Gut Microbes; 2020 May; 11(3):587-596. PubMed ID: 31564204
[TBL] [Abstract][Full Text] [Related]
39. Systems biology perspective for studying the gut microbiota in human physiology and liver diseases.
Altay O; Nielsen J; Uhlen M; Boren J; Mardinoglu A
EBioMedicine; 2019 Nov; 49():364-373. PubMed ID: 31636011
[TBL] [Abstract][Full Text] [Related]
40. Decipher enzymes from human microbiota for drug discovery and development.
Beliaeva MA; Wilmanns M; Zimmermann M
Curr Opin Struct Biol; 2023 Jun; 80():102567. PubMed ID: 36963164
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
